| Literature DB >> 29762539 |
Huiping Chen1, Xuewen Li2, Yongli Xu3, Kakei Lo4, Huizhen Zheng5, Haiyan Hu6, Jun Wang7, Yongcheng Lin8.
Abstract
The polar extract of the Dendrobium species or F. fimbriata (a substitute of Dendrobium), between the fat-soluble extract and polysaccharide has barely been researched. This report worked on the qualitative and quantitative studies of polar extracts from D. nobile, D. officinale, D. loddigesii, and F. fimbriata. Eight water-soluble metabolites containing a new diglucoside, flifimdioside A (1), and a rare imidazolium-type alkaloid, anosmine (4), were identified using chromatography as well as spectroscopic techniques. Their contents in the four herbs were high, approximately 0.9⁻3.7 mg/g based on the analysis of quantitative nuclear magnetic resonance (qNMR) spectroscopy. Biological activity evaluation showed that the polar extract of F. fimbriata or its pure component had good antioxidant and neuroprotective activity; compounds 1‒4 and shihunine (8) showed weak α-glucosidase inhibitory activity; 4 and 8 had weak anti-inflammatory activity. Under trial conditions, all samples had no cytotoxic activity.Entities:
Keywords: Dendrobium; Flickingeria fimbriata; antioxygenation; neuroprotection; qNMR; α-glucosidase inhibition
Mesh:
Substances:
Year: 2018 PMID: 29762539 PMCID: PMC6099805 DOI: 10.3390/molecules23051185
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1 and 4 (H-a and H-c were the target protons for content determination).
1H-NMR (400 MHz) and 13C-NMR (100 MHz) data of flifimdioside A (1) (in CD3OD, J in Hz).
| Position | Position | Position | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 37.7 t | 1.68 m, 1.16 m | 11 | 23.2 t | 1.61 m, 1.46 m | 1′ | 101.9 d | 4.33 d (7.6) |
| 2 | 24.1 t | 1.79 m, 1.55 m | 12 | 33.6 t | 2.29 m, 1.14 m | 2′ | 75.1 d | 3.26–3.18 m |
| 3 | 85.8 d | 3.38 m | 13 | 48.6 s | 3′ | 78.2 d | 3.37–3.27 m | |
| 4 | 39.4 s | 14 | 124.8 d | 5.52 s | 4′ | 71.9 d | 3.29 m | |
| 5 | 55.9 d | 1.15 m | 15 | 213.7 s | 5′ | 77.6 d | 3.37–3.27 m | |
| 6 | 21.2 t | 1.63 m, 1.23 m | 16 | 72.4 t | 4.86 d (18.4) | 6′ | 62.9 t | 3.86 m, 3.67 m |
| 7 | 36.7 t | 2.04 m, 2.11 m | 4.50 d (18.4) | 1″ | 104.2 d | 4.25 d (7.6) | ||
| 8 | 143.5 s | 17 | 27.5 q | 1.13 s | 2″ | 74.9 d | 3.26–3.18 m | |
| 9 | 51.9 d | 1.78 m | 18 | 17.3 q | 0.87 s | 3″ | 78.1 d | 3.37–3.27 m |
| 10 | 40.4 s | 19 | 29.1 q | 1.06 s | 4″ | 71.4 d | 3.29 m | |
| 20 | 15.1 q | 0.73 s | 5″ | 77.7 d | 3.37–3.27 m | |||
| 6″ | 62.7 t | 3.86 m, 3.67 m |
Figure 22D-NMR correlations of flifimdioside A (1).
Figure 3The 1H-NMR profiles of extracts. (A) F. fimbriata; (B) D. nobile; (C) D. officinale; and (D) D. loddigesii. The diagnostic signals of metabolites were labeled in the order number of metabolites; 1 = flifimdioside A; 2 = flickinflimoside B; 4 = anosmine; 5 = malic acid; 6 = 3-O-β-d-galactopyranosyl-β-d-galactopyranose; 8 = shihunine (Figure S1). The chemical shifts and splitting patterns of diagnostic signals are listed in Table S1.
The concentrations of water-soluble metabolites in the four crude herbs by qNMR a.
| Plant | Compound | Target Signal | Concentration (mg/g) |
|---|---|---|---|
| δ (ppm, Multiplicity Hz) | |||
| flifimdioside A ( | H-a/5.51 (s, 1H) | 0.97 | |
| flickinflimoside B ( | H-b/5.54 (s, 1H) | 1.63 | |
| syringaresinol-4′- | / | / | |
| 3- | H-e′/5.12 (d, 2.4, 1H) | 0.96 | |
| anosmine ( | H-c/4.11 (t, 3.6, 2H) | 3.79 | |
| malic acid ( | H-d/2.78 (dd, 10.8, 3.6, 1H) | 1.38 | |
| 3- | H-e/4.48 (d, 5.2, 1H) | 2.42 | |
| C-f/99.2 (s) | about 1.09 | ||
| C-f′/103.1 (s) | about 0.32 | ||
| C-f″/105.3 (s) | about 0.069 | ||
| shihunine ( | H-g/8.11 (dd, 4.4, 1.2, 1H) | 2.27 |
a Recorded on mg/g of crude drug; n = 3.
Biological activities of extracts and isolated metabolites expressed in IC50 μg/mL.
| DPPH | OH | α-glucosidase | NO | ||
|---|---|---|---|---|---|
| polar extract of | 131.8 | 274.7 | 396.7 | a.a a | |
| a.a | a.a | 40.3 | a.a | ||
| a.a | a.a | 45.8 | a.a | ||
| 48.1 | a.a | 40.4 | a.a | ||
| polar extract of | 1278.9 | a.a | 396.7 | 122 | |
| a.a | a.a | 17.7 | 16.1 | ||
| polar extract of | 1032.0 | 457.5 | 161.7 | a.a | |
| polar extract of | 317 | 486.3 | 682.2 | 130 | |
| a.a | a.a | 21.9 | 11.5 | ||
| n.t b | n.t | 7.7 | n.t | ||
| L-NG-monomethyl arginine citrate | n.t | n.t | n.t | 7.2 | |
| 2,6-ditertbutyl-4-methyl-phenol | 5.7 | n.t | n.t | n.t | |
| vitamin C | n.t | 6.3 | n.t | n.t |
a a.a: absence of activity; b n.t: not tested. All samples for bioactivity evaluation were prepared in DMSO.
Figure 4Effects of polar extract of F. fimbriata (A) and compound 3 (B) restraining glutamate-induced HT22 cell death. Data are presented as means ± standard deviation (n = 5); # p < 0.05 vs. the control (Con) group; ## p < 0.05 vs. model (Mod) group.